OrsoBio, Inc
2 clinical trials · 2 recruiting · INDUSTRY
Trials by OrsoBio, Inc
RECRUITINGPhase 1NCT05822544
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
The phase 1 portion of the study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-6740 after single- and...
Sponsor: OrsoBio, IncEnrolling: 5644 locations
Healthy SubjectsObesityType 2 Diabetes
RECRUITINGPhase 2NCT06564584
Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD
This is a Phase 2a, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of 2 dose levels of TLC-2716 in subjects with...
Sponsor: OrsoBio, IncEnrolling: 304 locations
HypertriglyceridemiaNonalcoholic Fatty Liver Disease